All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Prolonged survival of patients with peripheral T-Cell lymphoma after first-line intensive sequential chemotherapy with autologous stem cell transplantation

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F09%3A00009474" target="_blank" >RIV/61989592:15110/09:00009474 - isvavai.cz</a>

  • Alternative codes found

    RIV/61989592:15110/09:00009739

  • Result on the web

  • DOI - Digital Object Identifier

Alternative languages

  • Result language

    angličtina

  • Original language name

    Prolonged survival of patients with peripheral T-Cell lymphoma after first-line intensive sequential chemotherapy with autologous stem cell transplantation

  • Original language description

    Background: Nodal peripheral T-cell lymphomas (PTCLs) are infrequent subtypes of non-Hodgkin?s lymphomas.-The WHO classification recognizes three subgroups of nodal PTCL: peripheral T-cell lymphoma not otherwise specified-(PTCL, NOS), anaplastic large cell lymphoma (ALCL) and angioimmunoblastic lymphoma (AIL). The clinical-course is aggressive and despite multiagent chemotherapy, the median survival is about 2 years. Optimal first-line chemotherapy-is not established and the role of high-dose therapy with autologous stem cell support is still controversial.-Aim: To analyze the long-term outcome of PTCL patients treated with intensive first-line chemotherapy with highdose-therapy and autologous transplant consolidation. Method: Sequential chemotherapy protocol consisting of 3 cycles of CHOEP-21-like regimen (PACEBO), 1 cycle-of an ifosfamide and methotrexate-based regimen (IVAM) and a priming regimen with high-dose cytosine arabinoside-(HAM). Consolidation was provided with myeloablativ

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FD - Oncology and haematology

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    Z - Vyzkumny zamer (s odkazem do CEZ)<br>S - Specificky vyzkum na vysokych skolach

Others

  • Publication year

    2009

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Biomedical Papers

  • ISSN

    1213-8118

  • e-ISSN

  • Volume of the periodical

    153

  • Issue of the periodical within the volume

    1

  • Country of publishing house

    CZ - CZECH REPUBLIC

  • Number of pages

    4

  • Pages from-to

  • UT code for WoS article

  • EID of the result in the Scopus database